1. Home
  2. RBBN vs FENC Comparison

RBBN vs FENC Comparison

Compare RBBN & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ribbon Communications Inc.

RBBN

Ribbon Communications Inc.

HOLD

Current Price

$1.33

Market Cap

355.8M

Sector

Technology

ML Signal

HOLD

Logo Fennec Pharmaceuticals Inc.

FENC

Fennec Pharmaceuticals Inc.

SELL

Current Price

$9.98

Market Cap

350.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
RBBN
FENC
Founded
1997
1996
Country
United States
United States
Employees
N/A
35
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
355.8M
350.0M
IPO Year
2017
2010

Fundamental Metrics

Financial Performance
Metric
RBBN
FENC
Price
$1.33
$9.98
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
6
Target Price
$3.30
★ $17.67
AVG Volume (30 Days)
★ 1.2M
115.9K
Earning Date
10-27-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 170.97
N/A
EPS
N/A
★ 0.06
Revenue
N/A
★ $44,642,000.00
Revenue This Year
N/A
$62.55
Revenue Next Year
$5.15
$42.10
P/E Ratio
★ N/A
$172.50
Revenue Growth
★ N/A
N/A
52 Week Low
$1.35
$5.65
52 Week High
$4.09
$13.25

Technical Indicators

Market Signals
Indicator
RBBN
FENC
Relative Strength Index (RSI) 28.56 40.60
Support Level N/A $9.87
Resistance Level $2.11 $10.66
Average True Range (ATR) 0.10 0.49
MACD -0.03 -0.02
Stochastic Oscillator 6.14 12.90

Price Performance

Historical Comparison
RBBN
FENC

About RBBN Ribbon Communications Inc.

Ribbon Communications Inc provides communications technology to service providers and enterprises, offering software and high-performance hardware products, network solutions, and services for secure data and voice communications, as well as high-bandwidth networking for residential and enterprise customers across industries such as finance, education, government, utilities, and transportation. It operates through two segments: Cloud and Edge, which generate maximum revenue and deliver software-centric, cloud-native solutions for VoIP, VoLTE, VoNR, and unified communications, and IP Optical Networks, which support growing telecommunications traffic from 5G, distributed cloud computing, and other applications. The Company generates the majority of its revenue from the United States.

About FENC Fennec Pharmaceuticals Inc.

Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.

Share on Social Networks: